Form 4: Core Labs CAO Awarded Performance Shares

Core Laboratories' CAO & Treasurer, Teo Sow Hang, was granted 7,526 performance shares tied to Return on Invested Capital targets.

Summary

• Teo Sow Hang, Core Laboratories Inc.'s CAO & Treasurer, was granted 7,526 performance shares.
• The transaction date for this grant was February 12, 2026.
• The performance shares have a conversion or exercise price of $0.
• Vesting of the award is contingent upon continued employment (or death or disability while employed) and the satisfaction of specific performance criteria.
• The award will vest on December 31, 2028, following a three-year performance period from January 1, 2026, to December 31, 2028.
• 100% of the award vests if the company achieves the top 55th percentile of Return on Invested Capital (ROIC) among its Bloomberg Peer Group (BPG).
• 200% of the award vests if the company achieves at or above the 85th percentile of ROIC among the BPG.
• The number of common shares vesting will be interpolated on a straight-line basis between the 55th and 85th percentile of ROIC.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development as it aligns executive incentives with shareholder value creation through a performance-based equity award tied to a key efficiency metric, ROIC.

Positives

• The grant of performance shares aligns the executive's incentives directly with the company's long-term financial performance, specifically Return on Invested Capital (ROIC).
• Tying compensation to ROIC encourages efficient capital allocation and value creation for shareholders.
• The potential for 200% vesting provides a strong incentive for superior performance against industry peers.

Risks

• The performance shares may not vest if the company fails to meet the specified Return on Invested Capital (ROIC) targets relative to its Bloomberg Peer Group.
• The recipient's continued employment is a condition for vesting, meaning termination of employment could result in forfeiture of the unvested award.

Future Outlook

The future outlook for the granted performance shares is directly tied to Core Laboratories' ability to achieve specific Return on Invested Capital (ROIC) targets relative to its Bloomberg Peer Group over a three-year performance period ending December 31, 2028. The potential for 100% to 200% vesting incentivizes strong future financial performance.

Industry Context

StockSavvy.ai notes that performance-based equity awards, particularly those tied to metrics like Return on Invested Capital (ROIC) and benchmarked against a peer group, are a common and effective practice in the industry. This approach aligns executive compensation with long-term shareholder value creation and encourages efficient capital deployment, which is crucial in capital-intensive sectors.

Comparison to Industry Standards

• StockSavvy.ai observes that tying executive compensation to ROIC performance against a peer group (Bloomberg Peer Group) is a robust practice, similar to compensation structures seen at companies like Schlumberger or Halliburton, which also utilize relative performance metrics to ensure competitive and challenging targets.
• The use of a percentile ranking against a peer group is a sophisticated method to ensure that performance targets are relative to market conditions and industry trends, preventing payouts for subpar absolute performance during industry downturns.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential positive impact as executive compensation is directly linked to a key value-creation metric (ROIC), incentivizing management to improve capital efficiency and potentially increase shareholder returns.
• Employees (specifically Teo Sow Hang): Direct financial incentive through potential equity ownership, contingent on company performance and continued employment.

Next Steps

• The Compensation Committee will measure and determine the company's Return on Invested Capital (ROIC) performance against the Bloomberg Peer Group at the end of the performance period (December 31, 2028).
• The number of shares vesting will be determined based on the ROIC percentile achieved, with vesting occurring on December 31, 2028.

Key Dates

Keywords

Core Laboratories, CLB, Teo Sow Hang, Form 4, insider transaction, performance shares, executive compensation, ROIC, equity award, corporate governance